Empirical validation of an automated approach to data use oversight
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Cell Genomics
- Vol. 1 (2) , 100031
Abstract
No abstract availableKeywords
Funding Information
- European Bioinformatics Institute
- Intel Corporation
- International Business Machines Corporation
- Microsoft
- Pfizer
- Horizon 2020 Framework Programme (825775)
- National Human Genome Research Institute (U24HG010262)
- National Institutes of Health
This publication has 14 references indexed in Scilit:
- The Monarch Initiative in 2019: an integrative data and analytic platform connecting phenotypes to genotypes across speciesNucleic Acids Research, 2019
- Human Disease Ontology 2018 update: classification, content and workflow expansionNucleic Acids Research, 2018
- Common ELIXIR Service for Researcher Authentication and AuthorisationF1000Research, 2018
- Responsible sharing of biomedical data and biospecimens via the “Automatable Discovery and Access Matrix” (ADA-M)npj Genomic Medicine, 2018
- Simplifying research access to genomics and health data with Library CardsScientific Data, 2018
- A federated ecosystem for sharing genomic, clinical dataScience, 2016
- Consent Codes: Upholding Standard Data Use ConditionsPLOS Genetics, 2016
- The European Genome-phenome Archive of human data consented for biomedical researchNature Genetics, 2015
- Data use under the NIH GWAS Data Sharing Policy and future directionsNature Genetics, 2014
- The NCBI dbGaP database of genotypes and phenotypesNature Genetics, 2007